This report aims to provide detailed insights into the global bio decontamination market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

The Bio Decontamination Market is projected to reach USD 175 million by 2024 from USD 130 million in 2019, at a CAGR of 6.1%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=104696777

Key Factors Driving Market Growth:

The rising incidence of hospital-acquired infections (HAIs), growth in the pharmaceutical and biotechnology industries, and increasing outsourcing of bio decontamination services are factors driving the growth of the Bio Decontamination Industry.

The equipment segment commanded the largest share of the Bio Decontamination Market in 2019.

On the basis of product & service, the Bio Decontamination Equipment Industry is segmented into equipment, consumables, and services. In 2018, the equipment segment accounted for the largest market share of Decontamination Equipment Market. The launch of new and advanced instruments, portability, and the reduced need for manual intervention are key factors driving the growth of this segment.

Chamber decontamination held the largest share of the Bio Decontamination Market in 2019.

By type, the Bio Decontamination Equipment Market is segmented into room and chamber bio decontamination. In 2018, chambers accounted for the largest share of the market. The large share of this segment can be attributed to factors such as lower power consumption, smaller footprint, and cost-effectiveness.

Hydrogen Peroxide to dominate the Bio Decontamination Market in 2019.

On the basis of agent type, the Bio Decontamination Equipment Market is segmented into hydrogen peroxide, nitrogen dioxide, chlorine dioxide, and peracetic acid. In 2018, the hydrogen peroxide segment accounted for the largest share of the Bio Decontamination Industry. The advantages offered by hydrogen peroxide, such as material compatibility and safety with minimum residue, are the major factors contributing to its dominance in the Bio Decontamination Sector.

Regional Growth Analysis:

North America commanded the largest share of the Bio Decontamination Market in 2019.

On the basis of region, the Bio Decontamination Equipment Market is segmented into North America, Europe, Asia Pacific, and the Rest of the World. In 2018, North America commanded the largest share of the Bio Decontamination Industry. The large share of this regional segment can be attributed to the growing demand for bio decontamination technologies from the healthcare industry to minimize the occurrence of hospital-acquired infections and the presence of major players in the region.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=104696777

Key Players:

The major players operating in this market are STERIS (US), Ecolab, Inc. (US), TOMI Environmental Solutions, Inc (US), JCE Biotechnology (France), Fedegari Autoclavi SpA (Italy), Zhejiang Tailin Bioengineering Co., Ltd. (China), Noxilizer, Inc. (US), Howorth Air Technology Limited (UK), Wenzhou Weike Biological Laboratory Equipment Co., Ltd. (China), ClorDiSys Solutions Inc. (US), and Amira S.r.l. (Italy).

STERIS is the leading player in the bio decontaminationequipment market. The company offers a broad portfolio of bio decontamination equipment. The leading position of the company can be attributed to its strong brand recognition and wide geographical presence. Furthermore, STERIS is one of the few providers of bio decontamination services, further expanding its offerings in this market.

Some of the prominent players in the temperature monitoring system market are 3M (US), Abb Ltd. (Switzerland), Deltatrack (US), Emerson Electric (US), Fluke Corporation (Subsidiary Of Fortive Corporation) (US), Honeywell (US), Kelsius, Ltd. (Ireland), Monnit Corporation (US), and Omega Engineering (US).

Analysis of the developments in the temperature monitoring system market from 2016 to 2018 shows that new product launches, geographic expansions, mergers & acquisitions, and contracts were the most widely adopted growth strategies by players in the market. Players adopted these strategies to strengthen their market positions.

3M (US) the largest player operating the global temperature monitoring system market. Its large share can be attributed to its unique product portfolio for temperature monitoring devices. The company’s products offer core temperature monitoring systems for preoperative testing. 3M has a strong presence across the US, the Asia Pacific, and Europe. To provide improved product understanding to its customers, in May 2016, the company launched a compendium with the latest information and research findings related to 3M Bair Hugger. A strong brand image and widespread geographic coverage are the factors expected to drive the company’s growth in the temperature monitoring systems industry in the coming years.

Omega Engineering (US) is one of the leading companies in the global temperature monitoring system market. The company has a wide distribution network and operates across 30 countries. The company offers a broad range of technologically advanced products, which are used for process measurement and control of temperature, humidity, pressure, strain, force, flow, level, pH, and conductivity. Omega’s strong product offerings, wide distribution network, and extensive customer base give it a competitive edge in the temperature monitoring systems industry.

Expected Revenue Growth:

The temperature monitoring system market is projected to grow from USD 4.5 billion in 2019 to USD 5.4 billion by 2024, at a CAGR of 3.9%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=250125379

Major Revenue Segments:

The growth of this market is driven by rising manufacturing activity across a range of industries, as well as stringent regulations to ensure product quality (particularly in the food & beverage and pharmaceutical sectors). Technological advancements have introduced systems that are more efficient and capable of meeting a greater variety of needs than their predecessors did, which has stimulated their overall adoption.

Growth in the non-contact-based temperature monitoring systems segment can be attributed to factors such as increasing emphasis on continuous temperature monitoring, growing number of manufacturing and R&D activities, and advantages of contact-based temperature monitoring systems.

Non-contact-based temperature monitoring systems do not require direct contact with the intended energy source/object whose temperature needs to be measured. Based on type, the non-contact-based temperature monitoring system market is further classified into pyrometers & IR thermometers, thermal imagers, and fiber optic thermometers.

Regional Growth Analysis:

North America is one of the major revenue-generating regions in the global temperature monitoring systems industry. The large share of this regional segment can mainly be attributed to the presence of stringent regulatory guidelines and extensive regulatory compliance for product quality among target end-user industries, strong presence of major market players in the region, growing research pipeline among biopharmaceutical companies, and stringent regulatory norms for drug development and food & product safety regulations.

What This Report Will Provide?

This study involved four major activities in estimating the current size of the oligonucleotide synthesis market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market.

The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.

Expected Revenue Growth:

[246 Pages Report] The global oligonucleotide synthesis market is projected to reach USD 14.1 billion by 2026 from USD 6.3 billion in 2021, at a CAGR of 17.6%

Major Growth Boosters:

This market is experiencing significant growth due to the increasing research activities in the pharma and biotech sectors and the rising demand for innovative diagnostic and therapeutic techniques, increasing government funding, and the growing focus on personalized medicine.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=200829350

Recent Developments:

In 2020, Danaher Corporation (US) opened IDT China, an official business entity, to better serve its customer base in the region, reach out to new customers, and provide easier access to its complete portfolio of industry-leading products.

In 2020, Danaher (US) acquired the Biopharma business from General Electric Company's (US) Life Sciences division. This subsidiary is called ‘Cytiva’ and will act as a standalone operating company within Danaher's Life Sciences segment. This acquisition strengthened Danaher’s position in the oligo synthesizer and reagents market.

In 2020, Microsynth AG (Switzerland) launched Primer-Probe Sets for SARS-CoV-2.

In 2020, LGC Limited (UK) partnered with the Paraná Institute of Molecular Biology (IBMP) (Brazil) to supply reliable, high-quality custom GMP oligonucleotides and molecular products to develop a new molecular test for ZDC (zika, dengue, and chikungunya).

Key Questions Addressed in The Report:

1. Who are the top 10 players operating in the global oligonucleotide synthesis market?
2. What are the drivers, restraints, opportunities, and challenges in the oligonucleotide synthesis Industry?
3. What are the opportunities for stakeholders and provide details of the competitive landscape for key players?
4. What will be growth of oligonucleotide synthesis in North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa?

Regional Growth Analysis:

In 2020, North America accounted for the largest market share. The large share of this region can be attributed to the increasing R&D in life sciences, rising focus on improving the safety & quality of healthcare, rising demand for high-quality research tools for data reproducibility, and increasing focus on developing personalized therapeutics. The presence of many global players in this region is another key factor contributing to the large share of this market segment

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=200829350

Key Players in Oligonucleotide Synthesis Market:

The oligonucleotide synthesis market is dominated by a few globally established players such as Danaher Corporation (US), Thermo Fisher Scientific, Inc. (US), Merck KGaA (Germany), LGC Limited (UK), Maravai Life Sciences (US). The prominent players in the oligonucleotide therapeutics market are Biogen Inc. (US) and Sarepta Therapeutics, Inc. (US).

This report aims to provide detailed insights into the global mass spectrometry market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth:

The Mass Spectrometry Market size is expected to grow from an estimated USD 4.1 billion in 2020 to USD 5.6 billion by 2025, at a CAGR of 6.5%.

Key Factors Driving Market Growth:

The Increasing spending on pharmaceutical R&D across the globe, government regulations on drug safety, growing focus on the quality of food products, increase in crude and shale gas production, and growing government initiatives for pollution control and environmental testing are high growth prospects for the mass spectrometry market during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=437

The pharmaceutical industry end-user segment is expected to grow at the highest CAGR from 2020 to 2025.

Based on end user, the mass spectrometry market has been segmented into is pharmaceutical industry, biotechnology industry, research & academic institutes, environmental testing industry, food & beverage testing industry, petrochemical industry among and other end users. Pharmaceutical industries are among the key end-users of mass spectrometers. the availability of government and corporate funding for pharmaceutical research, growth of the pharmaceutical industry, and the presence of stringent regulatory guidelines for drug development and safety are some of the key factors driving the growth of this segment during the forecast period.

The hybrid mass spectrometry segment is expected to grow at the highest CAGR in the mass spectrometry market during the forecast period.

Based on the product, the foot and ankle devices market is segmented into hybrid mass spectrometry, single mass spectrometry and other technologies. The hybrid mass spectrometry segment is expected to witness the fastest growth during the forecast period. Advantages offered by hybrid mass spectrometers, such as rapid and high-resolution testing abilities with more accurate and precise results, are increasing its adoption. Consequently, the demand for mass spectrometry devices for high throughput screening is also growing. The hybrid mass spectrometry segment is further divided into Triple Quadrupole, Quadrupole ToF (Q-ToF), and Fourier Transform Mass Spectrometry (FTMS).

The life science research segment is expected to grow at the highest CAGR during the forecast period.

Based on application, the mass spectrometry market has been segmented into life science research, drug discovery, environmental testing, food testing, applied industries, clinical diagnostics and other applications. Among these, the life science research segment dominated the market in 2019. The increasing application of omics technology in diagnostics & biomarker identification and the increasing R&D expenditure and government funding for proteomics are expected to drive the market for this segment.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=437

Key Players:

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the mass spectrometry market. The major players in the mass spectrometry amrket are Thermo Fisher Scientific (US), SCIEX (US) Agilent Technologies (US), Waters Corporation (US), PerkinElmer (US), Shimadzu Corporation (Japan), Bruker (US), Analytik Jena (Germany), JEOL (Japan), Rigaku (Japan), DANI Instruments (Italy), LECO (US), and Hiden Analytical (UK).

These players are adopting various strategies to increase their share in the mass spectrometry market. Collaborations & agreements, new product launches, expansions and mergers have been a widely adopted strategy by the major players in the mass spectrometry industry.

This report aims to provide detailed insights into the global fluid management system market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth:

The global fluid management system marketis projected to reach USD 16.1 billion by 2025 from USD 8.5 billion in 2020, at a CAGR of 13.6% during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=153551158

Key Factors Driving Market Growth:

The Growth in this fluid management market is driven by the increasing number of minimally invasive surgeries, increasing ESRD patient base, technological advancements in fluid management systems, and an increase in government funds and grants worldwide for endosurgical procedures, rising number of hospitals, and investments in endoscopy and laparoscopy facilities are driving the market. The untapped potential in emerging markets and the rising use of single-use disposable devices and accessories are also expected to offer growth opportunities for players operating in the fluid management systems and accessories market.

The accessories and disposables segment is expected to grow at the highest CAGR during the forecast period

By product, the fluid management market is segmented into systems and accessories and disposables. The accessories and disposables s segment is expected to register the highest CAGR during the forecast period. The high growth of this segment can be attributed to the repeated purchase of accessories and disposables and an increasing number of minimally invasive surgeries.

The standalone fluid management systems segment is expected to account for the largest share of the fluid management systems and accessories market

By type, the fluid management system market is segmented into standalone fluid management systems and integrated fluid management systems. The standalone fluid management systems segment accounted for the largest share of the market in 2019. Standalone fluid management systems are less expensive than integrated systems. This is a major factor contributing to the high adoption of these products in hospitals, especially in developing countries.

The laparoscopy application segment is expected to grow at the highest CAGR during the forecast period

Based on application, the fluid management systems and accessories market is categorized into urology and nephrology, gastroenterology, gynecology/obstetrics, laparoscopy, bronchoscopy, cardiology, arthroscopy, otoscopy, dentistry, neurology, and other applications. The laparoscopy application segment is expected to register the highest CAGR during the forecast period. Growth in this application segment is mainly due to the growing shift towards minimally invasive procedures, which, in turn, boosts the number of laparoscopic surgeries performed worldwide.

Asia Pacific is expected to account for the highest CAGR for players operating in the fluid management system market

The Asia Pacific fluid management market is expected to grow at the highest CAGR from 2020 to 2025. Factors such as the favorable environment for the growth of the market in Japan, Japan’s Revitalization Strategy, penetration of key players into China’s fluid management system market, increasing infrastructure to support minimally invasive procedures in India, and growth of medical tourism and number of hospitals in Asian countries have contributed to the rapid growth of the market in the Asia Pacific.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=153551158

The prominent players in this fluid management market are Fresenius Medical Care AG & Co. KGaA (Germany), Baxter International Inc. (US), Cardinal Health, Inc. (US), Stryker Corporation (US), Olympus Corporation (Japan), B. Braun Melsungen AG (Germany), Medline Industries, Inc. (US), KARL STORZ GmbH & Co. KG (Germany), Ecolab Inc. (US), Smiths Medical (UK), Zimmer Biomet Holdings Inc. (US), Medtronic plc (Ireland), FUJIFILM Holdings Corporation (Japan), CONMED Corporation (US), Hologic, Inc. (US), Arthrex, Inc. (US), Thermedx, LLC. (US), COMEG Medical Technologies (Germany), and EndoMed Systems GmbH (Germany).

This report aims to provide detailed insights into the global healthcare provider network management market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

The global healthcare provider network management market is expected to reach USD 5.8 billion by 2025 from USD 2.9 billion in 2020, at a CAGR of 14.9%

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=231478238

Key Factors Driving Market Growth:

The implementation of stringent federal mandates in the US, the growing focus on improving the quality of care through the effective use of payer reporting requirements, the need to curtail escalating healthcare costs, and the in-house shortage of skilled personnel are the key drivers of the healthcare provider network management market growth. Rising patient population worldwide and subsequent increase in the burden on healthcare systems will further upsurge the demand for healthcare provider network management solutions.

The healthcare provider network management market includes Tier I and II vendors like Cognizant, Optum, Genpact, Infosys, Atos, and among others. The companies have a large market spread across various countries in North America, Europe, Asia Pacific and Rest of the World. The global COVID-19 outbreak has positively impacted the business to a certain extent. Companies are opting for provider network management infrastructure, as it helps to manage providers’ networks with greater efficiency, processes claims with greater accuracy, and reduces costs and errors while lowering the burden on providers, especially in these times of pandemic.

Services segment is anticipated to be the fastest growing segment during the forecast period

The market is segmented into services and software, based on the component. The services segment is estimated to command the largest share of the market in 2020, and is projected to register the highest CAGR during the forecast period. Factors such as the reduction in costs, improvement in claims auto adjudication rates, and improvements in operational efficiencies are expected to trigger the demand for provider network management services in the coming years.

Cloud-based delivery mode is projected to grow at the highest CAGR during the forecast period

The healthcare provider network management market is segmented into on-premise delivery mode and cloud-based delivery mode. The cloud-based delivery mode is expected to show high growth rate during the forecast period. The major factors driving the growth of the cloud-based solutions market are comparatively lower capital expenses and operational costs incurred alongside better scalability, flexibility, and affordability.

The Asia Pacific Healthcare provider network management services market to grow at the highest CAGR during the forecast period

While North America is expected to dominate the global healthcare provider network management market in 2020, followed by Europe, the Asia Pacific region is expected to register the highest CAGR during the forecast period. The high regional growth is attributed to the various factors such as the evolution of the healthcare ecosystem, growing burden on the healthcare industry, and increasing government initiatives for HCIT adoption in the region are supporting the growth of the healthcare provider network management market in this region.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=231478238

The major players operating in the healthcare provider network management services market include Cognizant (US), Ayasdi, Inc. (US), Change Healthcare (US), Optum, Inc. (US), Genpact Limited (US), Infosys BPM Ltd. (India), Atos Syntel, Inc. (France), Mphasis, Ltd. (India), SKYGEN USA (US), Evolent Health, Inc. (US), OSP Labs (US), HGS Ltd. (India), Virtusa Corp. (US), EXL (US), Vee Technologies (US), symplr (US), Appian (US), Inovalon (US), Wipro Limited (India), and Virsys12, LLC (US).

This report aims to provide detailed insights into the global EMEA 3D CBCT Market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

[115 Pages Report] The EMEA 3D CBCT market is valued at 178.4 Million in 2017 and is expected to grow at a CAGR of 9.0%

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=148086734

Key Factors Driving Market Growth:

The growing number of dentists is one of the major drivers for the growth of the dental CBCT market in this region. This increase, along with the subsequent establishment of new clinics and rising government spending on healthcare, has contributed to a growing demand for dental equipment like CBCT systems.

The dental segment accounted for the largest share of the EMEA 3D CBCT Market

On the basis of application, the market is broadly segmented into dental and non-dental applications. The dental applications segment further sub segmented into implantology, oral and maxillofacial surgery, orthodontics, endodontics, and other dental applications. The non-dental applications segment is sub segmented into ENT and radiology. The dental application segment accounted for the largest share of market in 2017. Large geriatric population in the European countries, technological enhancements, wide adoption of 3D CBCT systems in dental implant procedures, and the growing focus on the evaluation of post-treatment cases are factors attributed to the large share of dental application.

ENT segment accounted for the largest share of the non-dental application market

Based on the type, the non-dental application EMEA 3D CBCT Market is further segmented into ENT and radiology. In 2017, ENT segment accounted for the largest share of this market. This dominant share is attributed to the increasing use of CBT imaging in the diagnosis of ENT disorders due to advantages such as high spatial resolution, better visibility of small details, lower radiation exposure compared to traditional CT, patient convenience during examination, and compatibility of CBCT systems with surgical navigation/image-guided surgery systems during ear surgeries.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=148086734

Europe dominated the market:

Europe accounted for the largest share of the EMEA 3D CBCT Market in 2017, followed by the Middle East and Africa. The largest share of the European region is mainly attributed to the rising geriatric population, increasing awareness about oral healthcare, rising incidence of dental diseases, growing demand for advanced cosmetic dental procedures, growing dental tourism in some European countries, and the increasing number of dental clinics and hospitals in the region.

Even though the market is expected to grow at a high CAGR, the high cost of 3D CBCT system in addition to the lack of favorable reimbursement, is negatively impacting the adoption of new and advanced technologies in the EMEA 3D CBCT Market.

Key Players:

The key players in the EMEA 3D CBCT Market are Danaher Corporation (US), DENTSPLY SIRONA (US), Carestream Dental (US), Planmeca Group (Finland), VATECH (South Korea), CEFLA (Italy), J. MORITA CORPORATION (Japan), ACTEON GROUP (France), Asahi Roentgen (Japan), and Genoray (South Korea).

The study involved four major activities in estimating the current size for Infrared spectroscopy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter market breakdown and data triangulation was used to estimate the market size of segments and subsegments.

Revenue Growth Analysis:

[182 Pages Report] The infrared spectroscopy market is expected to reach USD 1.3 billion by 2025 from USD 1.0 billion in 2020, at a CAGR of 5.2%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=248742550

Key Factors Driving Market Growth:

Growth in the market can primarily be attributed to factors such as stringent regulations in the pharmaceutical industry, growing food safety concerns, increasing government in Infrared technologies and technological advancements in the market.

Infrared Spectroscopy Market Dynamics:

Driver: Growing Food Safety Concerns

Infrared spectroscopy is one of the most commonly used analytical techniques in quality testing and quality control of food. Food contamination is one of the biggest concerns worldwide, with more than 200 types of diseases caused by the consumption of unsafe food every year [Source: World Health Organization (WHO)]. Diarrheal diseases are the most common illnesses caused due to the consumption of contaminated food, and it is estimated that 600 million people (1 in every ten people in the world) fall sick from the consumption of contaminated food and 420,000 die every year [Source: World Health Organization (WHO)]. Food safety is thus a major concern for governments across the globe.

Opportunity: Emerging Economies

As compared to mature markets such as the US and Europe, emerging markets such as China and India are expected to provide significant growth opportunities for players operating in this market. Huge demand for spectroscopy is generated from China and India due to the Greenfield projects set up in various end-user industries in these countries. The life sciences industry in this region is also quite robust and is expected to contribute significantly to the growth of the infrared spectroscopy market in the coming years.

Pharmaceuticals and Biotechnology Holds Largest Market Share:

Based on the applications, the infrared spectroscopy market is segmented into food & beverage testing, pharmaceutical & biotechnology applications, industrial chemistry applications, environmental testing, and other applications (academic applications, forensic applications, biomonitoring, and agricultural applications). In 2020, the pharmaceutical and biotechnology applications segment to command the largest share of the infrared spectroscopy market. The large share of this segment can be attributed to the stringent regulations in the pharmaceutical industry.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=248742550

Regional Growth Analysis:

Geographically, North America dominated the global infrared spectroscopy market in 2020. However, the Asia Pacific market is expected to register the highest during the forecast period. The major factors driving the growth of the Asia Pacific market include strategic expansions by key players, increasing food safety concerns and adoption of technologically advanced products.

Key Players:

Key Players in Infrared Spectroscopy Market are Bruker Corporation (US), Agilent Technologies (US), Shimadzu Corporation (Japan), PerkinElmer (US), Thermo Fisher Scientific (US), FOSS (Denmark), HORIBA Ltd. (Japan), Teledyne Princeton Instruments (US), JASCO, Inc. (US), BaySpec (US), Spectra Analysis instruments (US), TeraView Ltd (UK), Microtech Instruments (US), EKSPLA (Lithuania), HÜBNER GmbH (Germany), and BATOP GmbH (Germany), Menlo Systems GmbH (Germany), Toptica Photonix AG (Germany), Advanced Photonix, Inc. (U.S.), and Advantest Corporation (Japan).

This report aims to provide detailed insights into the global lab automation market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth:

The lab automation market size will grow to USD 5.5 billion by 2025 from USD 4.3 billion in 2020, at a CAGR of 5.2% during the forecast period.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=1158

Key Factors Driving Market Growth:

The Increasing spending on pharmaceutical R&D, growing food safety concerns, standardization of workflows, stringent regulatory control in the healthcare industry are fuelling the growth of the market. Moreover, high demand in the emerging nation and the growth of the pharmaceutical and biotechnology industries are some of the other major factors driving the growth of this market.

The Automated Workstations segment is expected to dominate the lab automation market, by product type, during the forecast period.

Automated workstations are compact & standalone, capable of conducting a particular task unattended. Owing to the easy integration with both existing and upcoming systems are favorable options for customers looking to introduce automation in their labs. The Automated workstations is further segmented to automated liquid handling systems, microplate reader, automated Elisa system, automated nucleic acid purification systems. The automated liquid handling system are growing at the highest CAGR. Owing to an increase in the number of tests carried out in pharmaceutical labs for screening compounds, optimizing leads, determining drug properties with absorption, distribution, metabolism, and excretion (ADME), and toxicity has favored the argument for automation.

The drug discovery is expected to be the fastest-growing lab automation market, by application, during the forecast period.

The drug discovery, by application, laboratory automation market is estimated to grow at the fastest rate during the forecast period. This is mainly because of the increasing industry-academia collaboration for the development and use of fully automated, ultrahigh-throughput systems. Moreover, investments in automation permit the safer generation of data with improved accuracy, precision, reproducibility, and traceability, allowing drug discovery scientists to utilize higher–quality data in the hypothesis–driven research required to discover new medicines. Thus, growing the market of drug discovery segment.

Request For Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=1158

North America likely to emerge as the largest lab automation market

In this report, the laboratory automation market has been analyzed for four regions, namely, North America, Europe, Asia Pacific, Latin America, and Middle East & Africa. Growth in the North American market is also supported by the demand for the integration of laboratory systems, rising government funding for research, growth in biobanks, need for early drug discovery, and stringent regulatory requirements. Thus, North America dominated the market during the forecasted period.

To enable an in-depth understanding of the competitive landscape, the report includes the profiles of some of the top players in the market.

Some of the key players are Thermo Fisher Scientific, Inc. (US), PerkinElmer Inc,(US) Agilent Technologies (US), Danaher Corporation (US), F. Hoffmann-La Roche Ltd. (Switzerland), Danaher Corporation (US), and Tecan Group Ltd. (Switzerland).The leading players are adopting various strategies to increase their share in the lab automation market.

This report aims to provide detailed insights into the global capnography equipment market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

[232 Pages Report] The global capnography equipment market is expected to reach USD 436 million by 2027 from an estimated USD 334 million in 2021, at a CAGR of 4.6%

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=236876330

Key Factors Driving Market Growth:

Market growth is mainly driven by the development of portable/POC capnography devices, clinical benefits of capnography equipment over pulse oximetry, and increasing number of surgeries. In addition, healthcare industry in emerging countries are expected to offer growth opportunities for players in the capnography equipment market.

Market Drivers:

Development of portable/POC capnography devices

Capnography equipment is traditionally used for cardiology surgeries for patients under deep sedation and anesthesia. However, with the growing number of target patients for critical applications such as trauma and emergency cases, the demand for portable/point-of-care capnography equipment is expected to increase. In line with this changing market trend, key market players are increasingly focusing on developing portable/point-of-care or handheld capnography equipment that can be used for such applications that require easy device mobility and patient access. Examples of handheld capnography equipment include Microcap Handheld Capnographs (Medtronic Plc), Capnocheck II Hand-Held Capnograph/Oximeter/Carbon Dioxide Detector (Smiths Group Plc), and EMMA Capnograph and EMMA Mainstream Capnometer (Masimo Corporation).

Mainstream capnography segment is estimated to register the highest growth rate in the Capnography Equipment Market, by technology

Based on technology, the market is segmented into mainstream, sidestream, and microstream. The mainstream capnography segment accounted for 67.4% of the market in 2021. The advantages associated with mainstream capnography, such as ease of use and the ability to monitor breathing in intubated patients accurately, are expected to drive the growth of this market segment during the study period.

The Cardiac Surgeries segment, by application, accounted for the largest share of the global capnography equipment market in 2021

Based on application, the capnography equipment market is segmented into cardiac surgeries, trauma & emergency care, respiratory monitoring, and other applications. In 2021, the cardiac surgeries segment held 40.5% of the capnography equipment applications market. The large share of this segment is attributed to the increasing regulatory guidelines recommending capnography for cardiac surgeries and the rising number of cardiopulmonary surgeries performed across the globe.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=236876330

Regional Growth Analysis:

North America accounted for the largest share of 50.6% of the capnography equipment market, followed by Europe with a share of 25.5%. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period. This can primarily be attributed to the increase in government funding for the establishment of capnography equipment stations, stringent regulations that support the greater adoption of pollution monitoring technologies, and technological advancements in the field of environmental sensors.

Key Players:

Prominent players in the capnography equipment market include ZOLL Medical (Asahi Kasei) (Japan), Becton, Dickinson, and Company (US), Drägerwerk AG & Co. KGaA (Germany), Edan Instruments, Inc. (China), GE Healthcare (US), Hamilton Medical (Switzerland), Welch Allyn (a Hill-Rom company) (US), Koninklijke Philips N.V. (Netherlands), Masimo Corporation (US), Medtronic plc (Ireland), Mindray Medical (US), Nihon Kohden (Japan), Nonin Medical Inc.(US), Schiller (Switzerland) and Smiths Medical (UK).

This report aims to provide detailed insights into the global newborn screening market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

The global newborn screening market size is projected to reach USD 1.3 billion by 2026 from USD 0.9 billion in 2021, at a CAGR of 8.3%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141676244

Major Market Growth Drivers:

The Growth in this market is driven mainly by the growing awareness regarding early diagnosis of diseases in newborn, rising newborn screen rate, favorable government policies to conduct newborn screening.

The consumables segment accounted for the largest share of the newborn screening instruments market in 2019.

Based on the product, the newborn screening industry is segmented into consumables and instruments. The consumables further segmented into Assay kits & reagents and other consumables such as newborn screening cards and columns. In 2019, consumables accounted for the largest share of the newborn screening instruments market. The large share of this market segment is mainly due to the constant requirement for consumables in newborn screening. The increasing newborn screening rate across the globe also fuels the demand for consumables.

The dry blood spot tests segment accounted for the largest share of the newborn screening market in 2019.

The newborn screening industry, by test, is segmented into dry blood spot tests, hearing screening tests, and critical congenital heart defect (CCHD) screening tests. In 2019, the dry blood spot tests segment accounted for the largest share of the newborn screening instruments market due to the wide acceptance of dry blood spot tests for screening disorders. Most metabolic, hormonal, and genetic disorders are diagnosed using dry blood spot tests.

Regional Growth Analysis:

North America accounted for the largest share of the newborn screening market in 2019.

North America accounted for the largest share of the market in 2019. The large share of this segment can primarily be attributed to the rising incidence of newborn diseases, the availability of reimbursement for newborn screening test, and the strong presence of industry players in the region.

The Asia Pacific is expected to register the highest CAGR during the forecast period. Growth in this region is driven by the large newborn pool, increasing screening rate, and rising awareness regarding early diagnosis.

Key Market Players:

Some of the major players in the newborn screening market include Some of the leading players in the market are PerkinElmer (US), Demant A/S (Denmark), Natus Medical (US), Bio-Rad Laboratories (US), Danaher Corporation (US), and Medtronic (Ireland). Others include Chromsystems Instruments & Chemicals GmbH (Germany), Trivitron Healthcare (India), Baebies (US), Parseq Lab (Russia), and Recipe Chemicals+Instruments (Germany).

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=141676244

India, China, and Brazil provide significant opportunities to players in this market due to their high birth rates and increasing disposable income. According to the UN Children’s Fund, India records 25 million births every year, or nearly one-fifth of the global annual childbirths. The high birth rate and the availability of newborn screening in public hospitals indicates a strong demand for market products and consumables.

This report aims to provide detailed insights into the global diagnostic imaging services market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Expected Revenue Growth Analysis:

The Medical Imaging Services Market is projected to reach USD 693.4 billion by 2024 from USD 539.7 billion in 2019, at a CAGR of 5.1% from 2019 to 2024.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=17157849

Key Factors Driving Market Growth:

The major factors driving the growth of medical imaging market include the rapidly growing geriatric population and the subsequent increase in the prevalence of associated diseases and growing awareness about early disease detection and the widening scope of clinical applications. On the other hand, factors such as the high cost of diagnostic imaging systems and the low reimbursement structure for outpatient imaging facilities are likely to restrain the growth of the Diagnostic Imaging Services Market to a certain extent in the coming years.

Based on modality, the X-ray segment accounted for the largest share of the Diagnostic Imaging Services Market in 2018.

On the basis of modality, medical imaging services market is segmented into magnetic resonance imaging (MRI), ultrasound, computed tomography (CT), X-ray, nuclear imaging, and mammography. In 2018, the x-ray segment accounted for the largest share of medical imaging market. The key factors driving the growth of this market include the rising geriatric population, lower cost of X-rays as compared to other imaging modalities, favorable returns on investments, and technological advancements in X-ray imaging systems.

The hospitals segment held the largest share of the Diagnostic Imaging Services Market in 2018.

On the basis of end user, medical imaging services market is segmented into hospitals, diagnostic centers, ambulatory care centers, and research & academia. The hospitals segment held the largest share of medical imaging market in 2018. The large share of this segment can be attributed to the rising number of diagnostic imaging procedures performed in hospitals, increasing adoption of minimally invasive procedures in hospitals to improve the quality of patient care, and rising adoption of advanced imaging modalities to improve patient workflow efficiency in hospitals.

North America accounted for the largest share of the Diagnostic Imaging Services Market in 2018

Based on region, the medical imaging market is segmented into North America, Europe, the Asia Pacific, and RoW. North America accounted for the largest share of the market in 2018. The growth of the North American market is primarily driven by the increasing geriatric population, high incidence/prevalence of various diseases, the large number of diagnostic imaging centers/procedures, increasing awareness about the benefits of early diagnosis of diseases, and the rapid adoption of technologically advanced imaging systems in this region.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=17157849

Prominent players in the Diagnostic Imaging Services Market include RadNet, Inc (US), Sonic Healthcare (Australia), Dignity Health (US), Novant Health (US), Alliance Medical (UK), InHealth Group (UK), Medica Group (UK), Global Diagnostics (Australia), and Healthcare Imaging Services Pty Ltd. (Australia), among others.

RadNet (US) dominated the medical imaging services market in 2018. The company offers advanced imaging solutions, such as magnetic resonance imaging (MRI), computed tomography (CT), positron emission tomography (PET), nuclear medicine, mammography, ultrasound, diagnostic radiology (X-ray), fluoroscopy, and other related procedures. The company also offers a wide range of imaging services. To enhance its presence in medical imaging market, the company concentrates on partnerships and acquisitions & joint ventures.

This report aims to provide detailed insights into the physiotherapy equipment market. It provides valuable information on the type, procedure, application, and region in the market. Furthermore, the information for these segments, by region, is also presented in this report. Leading players in the market are profiled to study their product offerings and understand the strategies undertaken by them to be competitive in this market.

Revenue Growth Analysis:

The Physiotherapy Equipment Market is expected to reach USD 21.7 billion by 2025 from USD 16.6 billion in 2020, at a CAGR of 5.6% during the forecast period of 2020 to 2025.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65250228

Key Factors Driving Market Growth:

The Growth in physical therapy equipment market is driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease.

Opportunities in Emerging Markets:

China, Japan, India, Brazil, and Australia are emerging markets for physiotherapy equipment. These markets lack proper standards and government regulations and offer huge potential for providers unable to meet US standards.

In China, the healthcare infrastructure is in urgent need of modernization, owing to the growth in the aging population and the rising incidence of chronic disorders. In 2013, China had 83.7 million people with disabilities, of which 65 million cannot survive without assistive devices. The aging population (60+ years) will make up 20% of the Chinese population by 2025. Similarly, Japan is another country with one of the most rapidly increasing aging populations in the world. By 2025, 36% of the Japanese population will have crossed 60 years. India is also a high potential market for physiotherapy equipment on account of its huge aging population base, growing healthcare standards, and flourishing home healthcare sector. Moreover, the increasing competition in mature markets will compel physiotherapy manufacturers to focus on emerging markets.

Electrotherapy Equipment:

Based on type of equipment, the physiotherapy equipment market is segmented into electrotherapy equipment, ultrasound equipment, exercise therapy equipment, cryotherapy equipment, combination therapy equipment, continuous passive motion therapy equipment, shockwave therapy equipment, laser therapy equipment, traction therapy equipment, magnetic and pressure therapy equipment, and other physiotherapy equipment. In 2019, electrotherapy equipment segment accounted for the largest share of the physical therapy equipment market. The large share of this segment can be attributed to growing use of Neuromuscular electrical stimulation and therapeutic electrical stimulation in clinical settings for rehabilitaion.

Europe and Asia Pacific to Dominate The Market:

Geographically, the global physiotherapy equipment market is segmented into North America, Europe, the Asia Pacific, and Rest of the World )RoW). Asia Pacific is expected to show the highest growth rate during the forecast period. The high growth rate of this region can mainly be attributed to the rising geriatric population, the growing number of private sector hospitals, developments in primary healthcare infrastructure, and the inclination toward active lifestyles.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65250228

Key Players:

The leading players in physical therapy equipment market include DJO Global (US), BTL Industries Inc. (US), Performance Health (US), ITO Co., Ltd. (Japan), Enraf-Nonius B.V. (Netherlands), Dynatronics Corporation (US), Mectronic Medicale (Italy), EMS Physio Ltd. (UK), Whitehall Manufacturing (US), Zimmer MedizinSysteme GmbH (Germany), Zinex Inc. (US), STORZ Medical AG (Swotzerland), Life Care Systems (India), and Mettler Electronics Corp. (US).

Recent Developments:

1. In 2019, Colfax Corporation (US) acquired DJO Global (US). Through the acquisition Colfax Corporation will provide physical therapy and orthopedic products under the DJO brand.

2. In July 2018, Mectronic Medicale (Italy) launched Doctor Tecar XP, an electromagnetic tecar therapy stimulator.

3. In April 2018, DJO Global (US) entered into a strategic partnership with XPO Logistics (US) to manage portions of DJO’s North American distribution operations. Under this partnership, DJO opened a state-of-the-art distribution center in Dallas–Fort Worth, Texas, which is being managed by XPO.

4. In February 2018, EMS Physio Ltd. (UK) launched NeuroTrac PelviTone Dual-channel Stimulator.

This study involved four major activities in estimating the current size of the immuno-oncology assays market. Exhaustive secondary research was carried out to collect information on the market, its peer markets, and its parent market. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Both top-down and bottom-up approaches were employed to estimate the complete market size. After that, market breakdown and data triangulation procedures were used to estimate segments and subsegments' market size.

Expected Revenue Growth:

[214 Pages Report] The global immuno-oncology assays market is projected to reach USD 7.9 billion by 2026 from USD 4.4 billion in 2021, at a CAGR of 12.5%.

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=52562166

Key Factors Driving Market Growth:

Market growth is driven by the increased demand for personalized medicine, rising incidence of cancer and the growing adoption of targeted therapy, and the growing significance of companion diagnostics in drug development.

“In 2020, consumables segment accounted for the largest share of the immuno-oncology assays market, by product & service”

Based on product & service, the cancer cell-based assays market is segmented into consumables, instruments, and software & services. The consumables segment accounted for the largest share of the cancer cell-based assays market in 2020. The requirement of consumables in large numbers as compared to instruments is the main factor driving the growth of this segment.

In 2020, PCR segment accounted for the largest share in the market, by technology

The cancer cell-based assays market is segmented into PCR, immunoassay, NGS, flow cytometry, and ISH based on technology. In 2020, the PCR segment accounted for the largest share. The growing use of PCR in immuno-oncology biomarker identification and discovery research is driving the growth of this segment.

In 2020, research applications segment accounted for the largest share in the market, by application

The immuno-oncology assays market is segmented into research applications and clinical diagnostics based on application. In 2020, the research applications segment accounted for the largest share of the cancer cell-based assays market. The rising prominence of biomarker-based drug development is driving the growth of this segment.

Request Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=52562166

Regional Growth Analysis:

North America is the largest regional market for immuno-oncology assays

The global immuno-oncology assays market is segmented into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2020, North America accounted for the largest share of the global market. The North American cancer cell-based assays market growth can be attributed to the increasing demand for personalized medicine, rising adoption of advanced omics technologies for biomarker discovery, and growing government support for the discovery and development of biomarkers.

Key Players:

The major players operating in this market are Thermo Fisher Scientific, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), Agilent Technologies, Inc. (US), Illumina, Inc. (US), NanoString Technologies, Inc. (US), Sartorius AG (Germany), HTG Molecular Diagnostics, Inc. (US), QIAGEN N.V. (Netherlands), Merck Millipore (US), PerkinElmer, Inc. (US), Abbott Laboratories, Inc. (US), Guardant Health, Inc. (US), bioMérieux SA (France), Myriad Genetics, Inc. (US), MESO SCALE DIAGNOSTICS, LLC. (US), Seegene Inc. (South Korea), Bio-Rad Laboratories, Inc. (US), Charles River Laboratories, Inc. (US), Olink (Sweden), ASURAGEN, INC. (US), Invivoscribe, Inc. (US), Creative Biolabs (US), ReachBio LLC (US), and NMI Technologietransfer GmbH (Germany).

Thermo Fisher Scientific, Inc. held the leading position in the cancer cell-based assays market in 2020. The company has maintained a leading position in the market through its strong distribution networks across North America, Europe, the Asia Pacific, Latin America, and the Middle East and Africa. The company adopts organic growth strategies to increase its dominance in this market. For instance, in 2018, Thermo Fisher launched three assays, namely, Oncomine TCR Beta-SR Assay, Ion Torrent Oncomine Pan-Cancer Cell-Free Assay, and Torrent Oncomine Tumor Mutation Load Assay to address the challenges in this market.